Xinde Ou

Xinde Ou

Auto-generated profile, based on publicly available information

Xinde Ou

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in British Journal of Radiology
Verified
Journal Article
Open access
XOXinde Ou
Xinde Ou
DRDenise J van der Reijd
Denise J van der Reijd
DLDoenja Mj Lambregts
Doenja Mj Lambregts
BGBrechtje A. Grotenhuis
Brechtje A. Grotenhuis
BTbaukelien van triest
baukelien van triest
MMMonique Maas
Monique Maas
This review summarizes the current applications and benefits of imaging modalities for organ preservation in the treatment of rectal cancer. The concept of organ preservation in the treatment of rectal cancer has revolutionized the way rectal cancer is managed. Initially, organ preservation was limited to patients with locally advanced rectal cancer who needed neoadjuvant therapy to reduce tumor size before surgery and achieved complete response. However, neoadjuvant therapy is now increasingly utilized for smaller and less aggressive tumors to achieve primary organ preservation. Additionally, more intensive neoadjuvant strategies are employed to improve complete response rates and increase the chances of successful organ preservation. The selection of patients for organ preservation is a critical component of treatment, and imaging techniques such as digital rectal exam, endoscopy, and MRI are commonly used for this purpose. In this review, we provide an overview of what imaging modalities should be chosen and how they can aid in the selection and follow-up of patients undergoing organ-preserving strategies.